Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06421298
Status:
RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-05-10
Brief Title:
A Prospective Single-arm Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy
Sponsor:
Jinghui Wang
Organization:
Beijing Chest Hospital Capital Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-17
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-05-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-10
First Submit QC Date:
May 17 2024
Study First Post Date:
2024-05-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-17
Last Update Post Date:
2024-05-20
Last Update Post Date Type:
ACTUAL